QC
QuantumScape Corp (QS)·Q2 2025 Earnings Summary
Executive Summary
- Q2 2025 was a commercialization inflection: QuantumScape expanded its PowerCo collaboration with up to $131M in milestone-linked payments over two years and extended cash runway guidance into 2029, +6 months vs prior, while remaining non-exclusive and adding a JDA with a second global OEM .
- Financially, GAAP net loss was $114.7M, Adjusted EBITDA loss was $63.0M, and CapEx was $8.3M; liquidity ended at $797.5M and full-year guidance bands were narrowed (CapEx to $45–$65M, Adjusted EBITDA loss to $250–$270M) .
- EPS was -$0.20 vs consensus -$0.1847*, a modest miss; revenue remains pre-revenue with consensus at $0*, consistent with the development-stage licensing model .
- Stock-relevant catalysts: PowerCo cash inflows (invoice >$10M expected in Q3), B1 sample shipments enabled by the COBRA separator baseline, and the second OEM JDA reinforcing commercial validation .
What Went Well and What Went Wrong
What Went Well
- Expanded PowerCo collaboration brings up to $131M of milestone-linked cash inflows over two years; first milestones achieved and >$10M invoicing expected in Q3 2025, extending cash runway into 2029 .
- COBRA separator process entered baseline production, delivering a step-change in heat-treatment speed (more than 200× improvement vs 2023 and ~25× vs Raptor), enabling higher-volume B1 samples later this year .
- Management emphasized capital-light licensing model with near-term monetization of development activities and long-term high-margin royalties; “two sources of cash inflows” (NRE/development and royalties) validated by PowerCo .
What Went Wrong
- EPS modestly missed consensus (-$0.20 vs -$0.1847*), with GAAP net loss roughly flat QoQ; OpEx remained high at $123.6M amid scale-up and equipment automation investments .
- Accounting treatment of PowerCo cash inflow preliminarily not recognized as revenue; management will update in Q3, limiting near-term reported revenue optics despite customer payments .
- Execution risks persist: management reiterated challenges in scaling production, meeting technical milestones, and ensuring quality/reliability at volume during transition from Raptor to COBRA .
Financial Results
EPS, Revenue and Consensus Comparison
Values with asterisk retrieved from S&P Global.
Notes:
- EPS miss in Q2 2025 vs consensus; revenue remains pre-revenue, consistent with development-stage licensing model .
Operating Metrics
Q2 YoY Comparison
Segment breakdown: not applicable (pre-revenue) .
KPIs:
- Weighted-average shares outstanding rose sequentially (Q4: 525.9M; Q1: 548.0M; Q2: 561.7M), supporting EPS improvement despite similar net loss .
- COBRA baseline achieved; B1 sample shipments targeted in 2025 and field testing in 2026 .
Guidance Changes
Earnings Call Themes & Trends
Management Commentary
- “This upgraded PowerCo deal… clearly demonstrates the value of our solid-state lithium-metal technology… We are extending our cash runway forecast into 2029” — Siva Sivaram .
- “Our vision… provides two sources of cash inflows… monetize development activities… then collect licensing royalties as customers ramp” — Siva Sivaram .
- “Adjusted EBITDA loss was $63 million in Q2, in line with expectations… We narrow the range of our full year guidance for adjusted EBITDA loss to $250–$270 million” — Kevin Hettrich .
- “COBRA… improving the heat treatment by more than 200 times… most important technology element for gigawatt-hour scale production” — Siva Sivaram .
Q&A Highlights
- Second OEM JDA: Management confirmed a JDA with a global auto OEM to tailor QSE-5 specs toward eventual licensing, following the PowerCo playbook .
- PowerCo payments accounting: >$10M invoice in Q3; preliminary conclusion is not revenue; update to come in Q3 .
- Capacity and equipment: COBRA baseline requires downstream assembly throughput lift; industrialization and automation ongoing with PowerCo’s on-site team .
- Non-exclusivity & customization: QS retains non-exclusive status; platform customized by OEM (form factor/spec constraints) .
- Capital markets posture: Management values a strong balance sheet and will be strategic regarding equity issuance .
Estimates Context
- Q2 2025 EPS: -$0.20 vs consensus -$0.1847* → modest miss; revenue estimate $0* matches pre-revenue status .
- Consensus breadth: EPS estimates count 4*, revenue 1*, reflecting limited Street coverage and pre-revenue phase.
- Note: SPGI “EBITDA” definitions may differ from company “Adjusted EBITDA”; company reported Adjusted EBITDA loss $63.0M, while SPGI’s EBITDA actual field shows -$89.3M*, indicating definitional differences .
Values retrieved from S&P Global.
Consensus vs Actual
Values with asterisk retrieved from S&P Global.
Key Takeaways for Investors
- Near-term cash catalysts: Watch Q3 invoicing of >$10M from PowerCo and additional milestone-linked inflows over the next two years; although not revenue, these reduce GAAP net loss and extend runway .
- Execution milestones: COBRA baseline achieved; monitor downstream assembly throughput increases and B1 sample shipments timing through H2 2025 .
- Commercial validation: Expanded PowerCo agreement and second OEM JDA increase probability of eventual licensing revenues; non-exclusive approach preserves optionality .
- Guidance quality improving: Narrowed FY2025 CapEx ($45–$65M) and Adjusted EBITDA loss ($250–$270M) indicate cost control amid scale-up .
- EPS trajectory: EPS improved sequentially with higher share count; modest consensus miss underscores that investor focus should be on commercialization milestones rather than near-term GAAP EPS .
- Strategic model: Capital-light licensing with high-margin royalties remains intact; watch for progress on the $130M licensing prepayment trigger upon satisfactory technical progress .
- Trading implications: Headlines around partner inflows, B1 shipments, and new OEM agreements are likely stock catalysts; downside risk if scale-up or accounting treatment disappoints (e.g., inflows not recognized as revenue) .